Appia Bio
Company Information
Industry
Founded Year
2020
Overview
Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Get Contact Info for All Employees
Emily Lowe
Senior Director
Edmund Kim
Chief Operating Officer
Qi Wei
SVP, Head of TechOps
David Morse
VP Head of Quality at Appia Bio
Start with AroundDeal For Free!
Instant access. Cancel anytime
Sign Up to View Appia Bio’s Top Employees
Instant access. Cancel anytime
Similar Companies
Frequently Asked Questions Regarding Appia Bio
What is Appia Bio website?
https://www.appiabio.com/